Actively Recruiting

Phase 4
Age: 18Years - 55Years
All Genders
NCT04650321

Home Based Infusions for Ocrelizumab

Led by University of Colorado, Denver · Updated on 2021-06-10

110

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

U

University of Colorado, Denver

Lead Sponsor

G

Genentech, Inc.

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal is to assess the safety and effectiveness of home ocrelizumab infusion.

CONDITIONS

Official Title

Home Based Infusions for Ocrelizumab

Who Can Participate

Age: 18Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Current active patient of Rocky Mountain MS Center at the time of final study consent
  • Between 18 and 55 years of age at the time of final study consent
  • Diagnosis of primary progressive or relapsing MS as defined by the 2017 McDonald criteria
  • Has completed at least the first 600 mg dose of ocrelizumab
  • Physically resides in the Denver metro, Fort Collins, or Colorado Springs area at the time of final study consent
  • Has a Patient Determined Disease Steps (PDDS) between 0 and 6.5
  • Can complete patient reported outcomes in English
  • Able and willing to give informed consent electronically prior to participation
  • Treating neurologist agrees that continuing ocrelizumab is medically appropriate at the time of final study consent
Not Eligible

You will not qualify if you...

  • Pregnant, planning to become pregnant, or lactating at the time of final study consent and on the day of infusion
  • Previously participated in the SaROD trial at the Rocky Mountain MS Center site
  • Abnormal laboratory results deemed clinically inappropriate for home infusion by the treating neurologist at Rocky Mountain MS Center

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Amerita

Centennial, Colorado, United States, 80112

Actively Recruiting

Loading map...

Research Team

B

Brooke Valdez, BS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Home Based Infusions for Ocrelizumab | DecenTrialz